Keywords: ucb, reports, growth, pretax, profit, belgian, drugs

UCB reports 27% growth in pretax profit

Article | 31 July 2000

Print This

Belgian drugs and chemicals group UCB saw total sales rise 22.9% to 1.11billion euros ($1.03 billion) for the first six months of 2000 ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in